Skip page navigation

Message from the Vice Chancellor for Research

Welcome to the Office of the Vice Chancellor for Research of the Indiana University-Purdue University Indianapolis.

As one of the outstanding urban research universities in the United States, IUPUI is Indiana’s urban research university, located in the heart of Indianapolis, just blocks from the Indiana Government Center and Fortune 500 companies. IUPUI is Indiana University’s home campus for state wide programs in medicine, law, dentistry, nursing, health and rehabilitation science, and social work. Moreover, it excels in providing programs in art, business, education, engineering, informatics, journalism, liberal arts, library and information science, physical education, public and environmental affairs, and science.

The mission of the Office of the Vice Chancellor for Research is to advance the realization of world-class research and creative activities that address important national and global needs, and impact the economic development of Indiana and the nation. Our office provides a range of services supportive of research on the IUPUI campus. This includes resources supportive of faculty research, such as internal funding programs and workshops.

The strength of the research enterprise at IUPUI is manifested by the extensive level of research programs that are externally sponsored. This is a tribute to our outstanding faculty, students and staff, and a clear recognition of our superb research programs and facilities. Major research programs and initiatives include Translating Research Into Practice (TRIP), Signature Centers, and numerous other centers and institutes.

IUPUI is also increasingly growing its research partnerships with other campuses of Indiana University and Purdue University. Particularly, capitalizing on its central location and unique strengths, IUPUI is playing a key role in the advancement of Indiana’s research corridor linking IUPUI, Indiana University Bloomington, and Purdue University West Lafayette. An important priority is to play a key role in supporting the economic development of Indiana and the nation through the transfer and commercialization of research-generated intellectual property. Furthermore, as the university’s research efforts produce new knowledge and result in innovative technologies, new generations of students will have the opportunity to participate in ground-breaking research, gaining valuable knowledge and skills that upon graduation will serve them well as they launch their professional careers.

This site provides a wealth of information about the research enterprise at IUPUI. We invite you to learn more about our outstanding research programs, and welcome your comments and questions. You may contact us at 317-274-1020 or

Simon Atkinson, Ph.D.

Vice Chancellor for Research

Chancellor’s Professor and chair of biology in the School of Science, Simon Atkinson is an internationally respected National Institutes of Health-funded researcher specializing in kidney biology research. His background spans science, medicine and business, and his interactions in research and education extend far beyond his core research on kidney disease, with a record of numerous scientific collaborations with investigators across campus, especially in the Herman B Wells Center for Pediatric Research at the School of Medicine.

Atkinson first joined IU in 1994 as an assistant professor in the division of nephrology at the School of Medicine and served as graduate advisor and director of the Ph.D. program in biomolecular imaging and biophysics from 2004 to 2010. In 2010, he was appointed professor and chair of the department of biology in the School of Science.

In recent years, Atkinson’s research team has focused on efforts to understand and treat acute kidney injury, a common and life-threatening complication in seriously ill patients, using state-of-the-art methods including multiphoton microscopy, RNA interference and gene therapy.

Atkinson is also a biomedical entrepreneur and co-founded INphoton, a customized, proprietary company that provided microscopy services and consulting for pharmaceutical and biotech companies in the preclinical phase of drug discovery and development. He and other IU investigators also developed the technology used by Rene Medical, Inc., a start-up, preclinical medical device company that targets the treatment and prevention of acute kidney injury.

Atkinson is well respected by his peers and has over 40 publications in highly respected peer-reviewed journals. In addition to NIH funding, his research has garnered foundation and industry support.

Atkinson earned his B.S. in cell and molecular biology from King’s College London and his Ph.D. in molecular biology from the University of Cambridge in England. He also served a postdoctoral fellowship at Johns Hopkins University School of Medicine.